Vanguard Group Inc - Mar 31, 2025 SCHEDULE 13G Report for Akebia Therapeutics Inc Common Stock (AKBA)

Filing Manager: Vanguard Group Inc
Reporting Manager: The Vanguard Group
Security: Akebia Therapeutics Inc Common Stock
Symbol: AKBA
Shares outstanding: 236M shares
Disclosed Ownership: 12.7M shares
Ownership: 5.37%
Form type: SCHEDULE 13G
Date filed: 4/30/2025, 10:57 AM
Date of event: Mar 31, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	5.37%	12.7M	0	136K	Ashley Grim	Head of Global Fund Administration